Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

PDL BioPharma PE Ratio 2006-2020 | PDLI

Current and historical p/e ratio for PDL BioPharma (PDLI) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. PDL BioPharma PE ratio as of June 02, 2020 is 323.00.
  
PDL BioPharma PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-06-02 3.24 0.00
2020-03-31 2.82 $-0.68 0.00
2019-12-31 3.25 $-0.63 0.00
2019-09-30 2.16 $-0.04 0.00
2019-06-30 3.14 $0.30 10.47
2019-03-31 3.72 $-0.42 0.00
2018-12-31 2.90 $-0.46 0.00
2018-09-30 2.63 $-0.42 0.00
2018-06-30 2.34 $-0.46 0.00
2018-03-31 2.94 $0.69 4.26
2017-12-31 2.74 $0.72 3.81
2017-09-30 3.39 $0.51 6.65
2017-06-30 2.47 $0.45 5.49
2017-03-31 2.27 $0.09 25.22
2016-12-31 2.12 $0.39 5.44
2016-09-30 3.35 $1.06 3.16
2016-06-30 3.14 $1.40 2.24
2016-03-31 3.28 $1.84 1.78
2015-12-31 3.44 $2.00 1.72
2015-09-30 4.69 $1.71 2.74
2015-06-30 5.82 $1.90 3.07
2015-03-31 6.23 $1.95 3.19
2014-12-31 6.68 $1.89 3.54
2014-09-30 6.36 $1.96 3.24
2014-06-30 8.11 $1.71 4.74
2014-03-31 6.85 $1.81 3.79
2013-12-31 6.84 $1.73 3.96
2013-09-30 6.35 $1.68 3.78
2013-06-30 6.04 $1.64 3.68
2013-03-31 5.60 $1.54 3.64
2012-12-31 5.29 $1.47 3.60
2012-09-30 5.68 $1.37 4.14
2012-06-30 4.79 $1.33 3.60
2012-03-31 4.49 $1.19 3.77
2011-12-31 4.27 $1.15 3.72
2011-09-30 3.73 $0.73 5.12
2011-06-30 3.85 $0.69 5.58
2011-03-31 3.71 $0.61 6.08
2010-12-31 3.88 $0.51 7.61
2010-09-30 3.28 $0.86 3.81
2010-06-30 3.20 $0.90 3.56
2010-03-31 3.54 $1.06 3.34
2009-12-31 3.64 $1.14 3.20
2009-09-30 3.34 $1.23 2.72
2009-06-30 3.17 $1.33 2.38
2009-03-31 2.84 $1.11 2.56
2008-12-31 2.31 $0.44 5.24
2008-09-30 2.51 $0.05 50.17
2008-06-30 2.86 $-0.38 0.00
2008-03-31 1.99 $-0.49 0.00
2007-12-31 3.28 $-0.14 0.00
2007-09-30 4.05 $-0.79 0.00
2007-06-30 4.37 $-0.80 0.00
2007-03-31 4.07 $-0.98 0.00
2006-12-31 3.78 $-1.12 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.376B $0.055B
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $133.479B 14.70
Gilead Sciences (GILD) United States $94.279B 12.22
CSL (CSLLY) Australia $87.868B 0.00
Vertex Pharmaceuticals (VRTX) United States $74.319B 51.09
Regeneron Pharmaceuticals (REGN) United States $65.952B 25.42
Illumina (ILMN) United States $53.715B 55.20
Biogen (BIIB) United States $49.193B 8.42
Seattle Genetics (SGEN) United States $27.527B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.261B 11.28
Moderna (MRNA) United States $23.083B 0.00
Incyte (INCY) United States $22.118B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.519B 0.00
Genmab (GMAB) Denmark $20.100B 16.55
BioMarin Pharmaceutical (BMRN) United States $19.420B 176.05
Genmab (GNMSF) Denmark $18.291B 54.30
Alnylam Pharmaceuticals (ALNY) United States $15.336B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $13.136B 38.90
BeiGene (BGNE) Cayman Islands $12.996B 0.00
Exact Sciences (EXAS) United States $12.784B 0.00
BioNTech SE (BNTX) Germany $11.834B 0.00
Sarepta Therapeutics (SRPT) United States $11.680B 0.00
Bio-Techne Corp (TECH) United States $10.017B 66.18
QIAGEN (QGEN) Netherlands $9.946B 28.92
ARGENX SE-ADR (ARGX) Netherlands $9.646B 0.00
Horizon Therapeutics Public (HZNP) Ireland $9.518B 23.42
Guardant Health (GH) United States $8.355B 0.00
Immunomedics (IMMU) United States $7.717B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.620B 0.00
Exelixis (EXEL) United States $7.401B 25.95
Ascendis Pharma (ASND) Denmark $7.015B 0.00
Repligen (RGEN) United States $6.797B 119.22
Acceleron Pharma (XLRN) United States $5.235B 0.00
Adaptive Biotechnologies (ADPT) United States $4.958B 0.00
MyoKardia (MYOK) United States $4.809B 0.00
Emergent Biosolutions (EBS) United States $4.681B 30.68
Reata Pharmaceuticals (RETA) United States $4.650B 0.00
China Biologic Products (CBPO) China $4.316B 24.00
Zai Lab (ZLAB) China $4.300B 0.00
MorphoSys AG (MOR) Germany $4.259B 33.03
Mirati Therapeutics (MRTX) United States $4.258B 0.00
Global Blood Therapeutics (GBT) United States $4.185B 0.00
Vir Biotechnology (VIR) United States $4.168B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.152B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.063B 88.79
Momenta Pharmaceuticals (MNTA) United States $3.648B 0.00
Blueprint Medicines (BPMC) United States $3.589B 0.00
Bluebird Bio (BLUE) United States $3.583B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.391B 0.00
Halozyme Therapeutics (HALO) United States $3.285B 0.00
Amicus Therapeutics (FOLD) United States $3.267B 0.00
Novavax (NVAX) United States $3.061B 0.00
Denali Therapeutics (DNLI) United States $2.968B 0.00
Arena Pharmaceuticals (ARNA) United States $2.955B 0.00
UniQure (QURE) Netherlands $2.921B 0.00
NeoGenomics (NEO) United States $2.702B 197.31
Alkermes (ALKS) Ireland $2.640B 51.97
Alector (ALEC) United States $2.617B 0.00
Amarin (AMRN) Ireland $2.587B 0.00
Insmed (INSM) United States $2.525B 0.00
Fate Therapeutics (FATE) United States $2.461B 0.00
Viela Bio (VIE) United States $2.457B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.423B 0.00
Inovio Pharmaceuticals (INO) United States $2.349B 0.00
Principia Biopharma (PRNB) United States $2.013B 0.00
Eidos Therapeutics (EIDX) United States $1.884B 0.00
Epizyme (EPZM) United States $1.730B 0.00
Adverum Biotechnologies (ADVM) United States $1.707B 0.00
Zymeworks (ZYME) Canada $1.692B 0.00
Sangamo Therapeutics (SGMO) United States $1.667B 0.00
Ligand Pharmaceuticals (LGND) United States $1.641B 63.90
Twist Bioscience (TWST) United States $1.639B 0.00
Mesoblast (MESO) Australia $1.555B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.537B 0.00
Akcea Therapeutics (AKCA) United States $1.533B 0.00
Arcus Biosciences (RCUS) United States $1.521B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.514B 0.00
PHARMA MAR SA (PHMMF) Spain $1.514B 0.00
Editas Medicine (EDIT) United States $1.508B 0.00
Zealand Pharma (ZEAL) Denmark $1.446B 0.00
I-Mab (IMAB) China $1.422B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
Intra-Cellular Therapies (ITCI) United States $1.387B 0.00
REGENXBIO (RGNX) United States $1.372B 0.00
Beam Therapeutics (BEAM) United States $1.348B 0.00
NGM Biopharmaceuticals (NGM) United States $1.334B 0.00
Coherus BioSciences (CHRS) United States $1.324B 9.24
Arvinas (ARVN) United States $1.301B 0.00
Mersana Therapeutics (MRSN) United States $1.248B 0.00
Cytokineticsorporated (CYTK) United States $1.243B 0.00
Revance Therapeutics (RVNC) United States $1.238B 0.00
Myriad Genetics (MYGN) United States $1.132B 58.42
Intellia Therapeutics (NTLA) United States $1.075B 0.00
Sorrento Therapeutics (SRNE) United States $1.048B 0.00
Compugen (CGEN) Israel $1.048B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.959B 0.00
Pharming Group (PHGUF) Netherlands $0.948B 0.00
Athenex (ATNX) United States $0.931B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.904B 0.00
Cue Biopharma (CUE) United States $0.836B 0.00
NextCure (NXTC) United States $0.822B 0.00
Heska (HSKA) United States $0.799B 0.00
Cellectis S.A (CLLS) France $0.794B 0.00
Alcobra (ARCT) United States $0.792B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.761B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.739B 0.00
NantKwest (NK) United States $0.739B 0.00
Cara Therapeutics (CARA) United States $0.734B 0.00
Kala Pharmaceuticals (KALA) United States $0.731B 0.00
Dynavax Technologies (DVAX) United States $0.730B 0.00
Kadmon Holdings (KDMN) United States $0.730B 0.00
Codexis (CDXS) United States $0.729B 0.00
Agenus (AGEN) United States $0.710B 0.00
Retrophin (RTRX) United States $0.687B 0.00
Castle Biosciences (CSTL) United States $0.665B 0.00
Vericel (VCEL) United States $0.662B 122.25
Vanda Pharmaceuticals (VNDA) United States $0.649B 5.56
ZIOPHARM Oncology Inc (ZIOP) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.641B 17.05
Bellus Health (BLU) Canada $0.640B 0.00
Stemline Therapeutics (STML) United States $0.624B 0.00
Morphic Holding (MORF) United States $0.612B 0.00
Athersys (ATHX) United States $0.591B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.588B 0.00
Clovis Oncology (CLVS) United States $0.553B 0.00
Frequency Therapeutics (FREQ) United States $0.544B 0.00
MeiraGTx Holdings (MGTX) United States $0.538B 0.00
DBV Technologies S.A (DBVT) France $0.534B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
AnaptysBio (ANAB) United States $0.529B 0.00
Cel-Sci (CVM) United States $0.527B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.521B 0.00
Scholar Rock Holding (SRRK) United States $0.519B 0.00
AC Immune SA (ACIU) Switzerland $0.499B 0.00
UROGEN PHARMA (URGN) United States $0.496B 0.00
BioDelivery Sciences (BDSI) United States $0.482B 25.37
Anika Therapeutics (ANIK) United States $0.481B 15.48
Autolus Therapeutics (AUTL) United Kingdom $0.481B 0.00
VBI Vaccines (VBIV) United States $0.459B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.459B 0.00
Protagonist Therapeutics (PTGX) United States $0.453B 0.00
Prothena (PRTA) Ireland $0.435B 0.00
Syros Pharmaceuticals (SYRS) United States $0.432B 0.00
Puma Biotechnology (PBYI) United States $0.417B 0.00
Albireo Pharma (ALBO) United States $0.409B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.398B 0.00
MiMedx (MDXG) United States $0.398B 0.00
Merus (MRUS) Netherlands $0.396B 0.00
ANI Pharmaceuticals (ANIP) United States $0.379B 7.51
Seres Therapeutics (MCRB) United States $0.372B 0.00
Precision BioSciences (DTIL) United States $0.370B 0.00
CytomX Therapeutics (CTMX) United States $0.370B 0.00
Intrexon (PGEN) United States $0.369B 0.00
WAVE Life Sciences (WVE) Singapore $0.349B 0.00
Avid Bioservices (CDMO) United States $0.341B 0.00
Selecta Biosciences (SELB) United States $0.338B 0.00
Kamada (KMDA) Israel $0.336B 13.98
Geron (GERN) United States $0.329B 0.00
Menlo Therapeutics (MNLO) United States $0.323B 0.00
OSMOTICA PHARM (OSMT) United States $0.317B 0.00
Verastem (VSTM) United States $0.312B 0.00
MannKind (MNKD) United States $0.307B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.304B 0.00
ChromaDex (CDXC) United States $0.293B 0.00
Pfenex (PFNX) United States $0.277B 0.00
Aduro Biotech (ADRO) United States $0.272B 0.00
Liquidia Technologies (LQDA) United States $0.272B 0.00
Abeona Therapeutics (ABEO) United States $0.270B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.268B 0.00
Spero Therapeutics (SPRO) United States $0.267B 0.00
Starpharma Holdings (SPHRY) Australia $0.266B 0.00
ADMA Biologics Inc (ADMA) United States $0.264B 0.00
Cellular Biomedicine (CBMG) United States $0.255B 0.00
Affimed (AFMD) Germany $0.248B 0.00
Fortress Biotech (FBIO) United States $0.247B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.246B 0.00
Exicure (XCUR) United States $0.243B 0.00
Prometic Life Sciences (LMNL) Canada $0.242B 0.00
HOOKIPA Pharma (HOOK) United States $0.236B 0.00
Gritstone Oncology (GRTS) United States $0.234B 0.00
Sutro Biopharma (STRO) United States $0.232B 0.00
XOMA (XOMA) United States $0.221B 0.00
POXEL SA FRANCE (PXXLF) France $0.219B 0.00
Northwest Biotherapeutics (NWBO) United States $0.214B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.205B 3.10
GENFIT S.A (GNFT) France $0.204B 0.00
ARAVIVE, INC (ARAV) United States $0.203B 0.00
IVERIC Bio (ISEE) United States $0.202B 0.00
Pluristem Therapeutics (PSTI) Israel $0.198B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.198B 0.00
IBio (IBIO) United States $0.196B 0.00
VTv Therapeutics (VTVT) United States $0.193B 0.00
Aytu Bioscience (AYTU) United States $0.190B 0.00
Five Prime Therapeutics (FPRX) United States $0.190B 0.00
Kindred Biosciences (KIN) United States $0.186B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.182B 0.00
Cerecor (CERC) United States $0.176B 0.00
Celyad SA (CYAD) Belgium $0.174B 0.00
PHASEBIO PHARMA (PHAS) United States $0.170B 0.00
Dyadic (DYAI) United States $0.166B 0.00
Aptinyx (APTX) United States $0.165B 0.00
TELA Bio (TELA) United States $0.160B 0.00
Orgenesis (ORGS) United States $0.160B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.159B 0.00
Cidara Therapeutics (CDTX) United States $0.150B 0.00
Arbutus Biopharma (ABUS) Canada $0.149B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
Enzo Biochem (ENZ) United States $0.143B 0.00
Trevena (TRVN) United States $0.143B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.133B 0.00
Theratechnologies (THTX) Canada $0.132B 0.00
Antibe Therapeutics (ATBPF) Canada $0.132B 0.00
VolitionRX (VNRX) United States $0.128B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.123B 0.00
Applied Genetic Technologies (AGTC) United States $0.123B 0.00
Palatin Technologies (PTN) United States $0.121B 3.11
CorMedix Inc (CRMD) United States $0.120B 0.00
AIT Therapeutics (XAIR) United States $0.117B 0.00
Checkpoint Therapeutics (CKPT) United States $0.115B 0.00
Protalix BioTherapeutics (PLX) Israel $0.112B 0.00
Lumos Pharma (LUMO) United States $0.111B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.110B 0.00
Cyclerion Therapeutics (CYCN) United States $0.107B 0.00
Eton Pharmaceuticals (ETON) United States $0.105B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.105B 0.00
Windtree Therapeutics (WINT) United States $0.105B 0.00
Oncobiologics (OTLK) United States $0.102B 0.00
Organovo Holdings (ONVO) United States $0.090B 0.00
AquaBounty Technologies (AQB) United States $0.090B 0.00
Catalyst Biosciences (CBIO) United States $0.089B 0.00
SESEN BIO, INC (SESN) United States $0.089B 0.00
AnPac Bio-Medical Science (ANPC) China $0.086B 0.00
Celsion (CLSN) United States $0.086B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
Synlogic (SYBX) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Emmaus Life Sciences (EMMA) United States $0.078B 0.00
Proteostasis Therapeutics (PTI) United States $0.074B 0.00
Stealth BioTherapeutics (MITO) United States $0.069B 0.00
Happiness Biotech Group (HAPP) China $0.069B 0.00
DiaMedica Therapeutics (DMAC) United States $0.066B 0.00
Vaccinex (VCNX) United States $0.062B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.061B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.057B 0.00
Signal Genetics (MGEN) United States $0.056B 0.00
Apricus Biosciences (SEEL) United States $0.053B 0.00
Soligenix (SNGX) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Celldex Therapeutics (CLDX) United States $0.050B 0.00
Prima BioMed (IMMP) Australia $0.050B 0.00
Cocrystal Pharma (COCP) United States $0.049B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.049B 0.00
OvaScience (MLND) United States $0.045B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.045B 0.00
Advaxis (ADXS) United States $0.043B 0.00
Pulmatrix (PULM) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.041B 0.00
Cesca Therapeutics (THMO) United States $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.037B 0.00
TrovaGene (CRDF) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
Curis (CRIS) United States $0.030B 0.00
BioCardia (BCDA) United States $0.029B 0.00
TOCAGEN INC (TOCA) United States $0.029B 0.00
Stellar Biotechnologies (EDSA) Canada $0.028B 0.00
Evogene (EVGN) Israel $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Spherix (AIKI) United States $0.025B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.025B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Bionano Genomics (BNGO) United States $0.022B 0.00
Novogen (KZIA) Australia $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
VIVUS (VVUS) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Unum Therapeutics (UMRX) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00